featured
Expanding Access to Newer Type 2 Diabetes Medications in Low- and Middle-Income Countries
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis
Lancet Diabetes Endocrinol 2021 Dec 01;9(12)825-836, Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC)From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.